Pieris Pharmaceuticals (PIRS)

Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a) On June 22, 2022, the Company held the Annual Meeting. Of the 74,101,330 shares of common stock of the Company issued and outstanding and eligible to vote as of the record date of April 25, 2022, a quorum of 50,793,281 shares of common stock, or 68.54% of the outstanding shares, were present in person or by proxy.

(b) At the Annual Meeting, the stockholders: (1) elected each of James Geraghty, Ann Barbier, M.D., Ph.D., and Maya R. Said, Sc.D. to the Company’s Board of Directors as Class II directors, each to serve for a three-year term expiring at the 2025 annual meeting of stockholders (“Election of Directors”); (2) approved an amendment to the 2020 EIP (the “2020 EIP Amendment Approval”); (3) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 (“Auditor Ratification”); and (4) approved, on a non-binding basis, the compensation of named executive officers (“Say on Pay”). A more complete description of each of these matters is set forth in the Proxy Statement.

The number of votes cast in favor or against or withheld by the stockholders and, where applicable, the number of abstentions and the number of broker non-votes on each of the foregoing matters are set forth below.

1. Election of Directors:

NameVotes ForVotes WithheldBroker Non-Votes
James Geraghty24,966,0027,343,44718,483,832
Ann Barbier, M.D., Ph.D.28,903,9773,405,47218,483,832
Maya R. Said, Sc.D.28,902,9763,406,47318,483,832

2. 2020 EIP Amendment Approval:

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes

3. Auditor Ratification:

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes

4. Say on Pay:

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes